upexi inc - UPXI

UPXI

Close Chg Chg %
0.80 -0.04 -4.40%

Closed Market

0.77

-0.04 (4.40%)

Volume: 1.21M

Last Updated:

Oct 23, 2026, 4:00 PM EDT

Company Overview: upexi inc - UPXI

UPXI Key Data

Open

$0.81

Day Range

0.76 - 0.82

52 Week Range

0.54 - 5.25

Market Cap

$76.72M

Shares Outstanding

88.18M

Public Float

74.38M

Beta

-0.23

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$3.72

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.53M

 

UPXI Performance

1 Week
 
-21.39%
 
1 Month
 
-37.76%
 
3 Months
 
-4.32%
 
1 Year
 
-84.41%
 
5 Years
 
-99.35%
 

UPXI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About upexi inc - UPXI

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.

UPXI At a Glance

Upexi, Inc.
3030 North Rocky Point Drive
Tampa, Florida 33607
Phone 1-701-353-5425 Revenue 25.00M
Industry Pharmaceuticals: Other Net Income -246,064,698.00
Sector Health Technology 2026 Sales Growth 58.102%
Fiscal Year-end 06 / 2027 Employees 10
View SEC Filings

UPXI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.993
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -5.04
Enterprise Value to Sales 6.341
Total Debt to Enterprise Value 1.414

UPXI Efficiency

Revenue/Employee 2,499,802.80
Income Per Employee -24,606,469.80
Receivables Turnover 50.843
Total Asset Turnover 0.164

UPXI Liquidity

Current Ratio 1.642
Quick Ratio 1.638
Cash Ratio 1.622

UPXI Profitability

Gross Margin 87.653
Operating Margin -127.647
Pretax Margin -984.336
Net Margin -984.336
Return on Assets -161.923
Return on Equity -1,356.342
Return on Total Capital -144.509
Return on Invested Capital -245.778

UPXI Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 131.604
Total Debt to Total Assets 124.411
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 95.612
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Upexi Inc - UPXI

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
80.68M 26.00M 15.81M 25.00M
Sales Growth
+80.95% -67.77% -39.19% +58.10%
Cost of Goods Sold (COGS) incl D&A
52.58M 16.85M 5.70M 3.09M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.46M 3.68M 757.76K 456.25K
Depreciation
1.25M 1.27M 681.00K 379.49K
Amortization of Intangibles
4.21M 2.41M 76.76K 76.76K
COGS Growth
+134.68% -67.94% -66.18% -45.86%
Gross Income
28.10M 9.15M 10.11M 21.91M
Gross Income Growth
+26.68% -67.45% +10.55% +116.72%
Gross Profit Margin
+34.83% +35.18% +63.94% +87.65%
2023 2024 2025 2026 5-year trend
SG&A Expense
35.65M 22.54M 22.99M 53.82M
Research & Development
- - - -
-
Other SG&A
35.65M 22.54M 22.99M 53.82M
SGA Growth
+43.56% -36.77% +1.96% +134.15%
Other Operating Expense
- - - -
-
Unusual Expense
3.95M 8.50M (375.47K) 186.94M
EBIT after Unusual Expense
(11.50M) (21.89M) (12.50M) (218.85M)
Non Operating Income/Expense
(2.21M) (585.64K) (10.74K) (13.65M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.76M 3.12M 1.17M 13.56M
Interest Expense Growth
+2,111.75% -34.38% -62.44% +1,055.41%
Gross Interest Expense
4.76M 3.12M 1.17M 13.56M
Interest Capitalized
- - - -
-
Pretax Income
(18.47M) (25.60M) (13.68M) (246.06M)
Pretax Income Growth
-620.30% -38.61% +46.55% -1,698.17%
Pretax Margin
-22.90% -98.47% -86.55% -984.34%
Income Tax
- - (3.05M) (332.10K)
-
Income Tax - Current - Domestic
349.26K 12.70K 13.56K 13.56K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(3.40M) (344.80K) (13.56K) (13.56K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(15.42M) (25.27M) (13.68M) (246.06M)
Minority Interest Expense
- - - (559.97K)
-
Net Income
(14.86M) (25.27M) (13.68M) (246.06M)
Net Income Growth
-607.44% -70.04% +45.85% -1,698.17%
Net Margin Growth
-18.42% -97.20% -86.55% -984.34%
Extraordinaries & Discontinued Operations
- - (2.07M) 1.16M
-
Discontinued Operations
- - (2.07M) 1.16M
-
Net Income After Extraordinaries
(16.93M) (24.11M) (13.68M) (246.06M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(16.93M) (24.11M) (13.68M) (246.06M)
EPS (Basic)
-18.9398 -23.4682 -1.7291 -3.8726
EPS (Basic) Growth
-631.32% -23.91% +92.63% -123.97%
Basic Shares Outstanding
893.90K 1.03M 7.91M 63.54M
EPS (Diluted)
-18.9398 -23.4682 -1.7291 -3.8726
EPS (Diluted) Growth
-631.32% -23.91% +92.63% -123.97%
Diluted Shares Outstanding
893.90K 1.03M 7.91M 63.54M
EBITDA
(2.09M) (9.72M) (12.12M) (31.45M)
EBITDA Growth
-689.93% -364.23% -24.68% -159.57%
EBITDA Margin
-2.59% -37.38% -76.64% -125.82%

Snapshot

Average Recommendation BUY Average Target Price 1.30
Number of Ratings 1 Current Quarters Estimate -0.19
FY Report Date 12 / 2026 Current Year's Estimate N/A
Last Quarter’s Earnings -0.23 Median PE on CY Estimate N/A
Year Ago Earnings -3.87 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 N/A N/A
Mean Estimate -0.19 -0.14 N/A N/A
High Estimates -0.19 -0.14 N/A N/A
Low Estimate -0.19 -0.14 N/A N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Upexi Inc - UPXI

Date Name Shares Transaction Value
Nov 20, 2025 Gene Z. Salkind Director 569,470 Open market or private purchase of non-derivative security Non-derivative transaction at $2.65 per share 1,509,095.50
Nov 20, 2025 Gene Z. Salkind Director 168,750 Open market or private purchase of non-derivative security Non-derivative transaction at $2.81 per share 474,187.50

Upexi Inc in the News